companydata.dkcompanydata.dk

ENDOGEN ApS: Financial statements 2018

CVR: 29813337

Source: annual report 2018, Danish Business Authority

27/10/201726/10/2018

ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -25,583 and a net result of DKK -25,908 compared with DKK -7,059 the year before. Equity in the 2018 report amounted to DKK 83,421. The solvency ratio was 78.8%. The company had 1 employee in the financial year.

Gross Profit
DKK -25,583
Profit/Loss
DKK -25,908
Equity
DKK 83,421
Total Assets
DKK 105,921
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018--26 t.-26 t.83 t.1
20170-7 t.-7 t.36 t.-
20160-13 t.-14 t.43 t.-
201519 t.-16 t.-16 t.56 t.-
201419 t.-36 t.-37 t.70 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Simon Glerup Pedersen steps down as adm. dir. of ENDOGEN ApSNov 23, 2018

As of November 23, 2018, Simon Glerup Pedersen has stepped down as adm. dir. of ENDOGEN ApS.

ENDOGEN ApS: The 2017 annual report is outMar 7, 2018

ENDOGEN ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -7,059.

About ENDOGEN ApS

ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.

Source: annual report 2025, Danish Business Authority